BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Beatriz M, Lopes C, Ribeiro ACS, Rego ACC. Revisiting cell and gene therapies in Huntington's disease. J Neurosci Res 2021;99:1744-62. [PMID: 33881180 DOI: 10.1002/jnr.24845] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu W, Li L, Jiang J, Wu M, Lin P. Applications and challenges of CRISPR-Cas gene-editing to disease treatment in clinics. Precis Clin Med 2021;4:179-91. [PMID: 34541453 DOI: 10.1093/pcmedi/pbab014] [Reference Citation Analysis]
2 Kim A, Lalonde K, Truesdell A, Gomes Welter P, Brocardo PS, Rosenstock TR, Gil-Mohapel J. New Avenues for the Treatment of Huntington's Disease. Int J Mol Sci 2021;22:8363. [PMID: 34445070 DOI: 10.3390/ijms22168363] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]